Tag
A next-generation obesity drug, Retatrutide, shows up to 25% weight loss in clinical trials, building on GLP-1 based treatments by combining GLP-1, GIP, and glucagon hormones.
RonanRx offers personalized GLP-1 treatments with physician oversight and compounding pharmacies, focusing on tailored dosing and support for side effects.
The article explores how turnkey telehealth services enable virtually anyone—from established companies like JustAnswer to influencers—to sell GLP-1 weight loss drugs online, highlighting the rapid expansion of the digital health market and the role of infrastructure providers.
A journalist recounts being scammed by an online telehealth service that charged him for unwanted GLP-1 medications and refused refunds, highlighting a broader pattern of consumer fraud in the growing online weight-loss drug market.
The article explains the biochemical mechanism of GLP-1 agonists, including the new drug retatrutide, and how they regulate appetite and energy metabolism by mimicking natural hormones.